Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination.
Oncoimmunology
; 2(3): e23430, 2013 Mar 01.
Article
em En
| MEDLINE
| ID: mdl-23802085
ABSTRACT
Accumulating evidence demonstrates the importance of CD4+ T cells in antitumor immune responses. Identifying promiscuous MHC class II-binding peptides derived from relevant tumor-associated antigens that specifically target CD4+ helper T cells in vivo represent a powerful approach to fully exploit these cells for anticancer immunotherapy.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article